For more than two decades, AquaBounty has been developing its genetically modified AquAdvantage salmon, which the company plans to grow in land-based recirculating aquaculture systems (RAS).
Since the company gained regulatory approval, and finally had an import alert lifted by the U.S. Food and Drug Administration in May, the it has been busy growing the first batches of genetically modified salmon at its land-based facility in Indiana.
…
Now that its salmon has started its growing process, the company is already setting its sights on developing markets for the product, both in the United States and abroad.
…
“We’ve begun conversations with a number of states in the U.S. in terms of where the next facility will be,” [AquaBounty CEO Sylvia Wulf said]. “We’re looking at probably three to five different sites in the U.S., we’re looking at additional sites in Canada as well.”
…
Wulf said the company also aspires to take its aquaculture model overseas …. “We have approval for field trials in China, and the Chinese government has been very receptive in trying to navigate the regulatory approval process.”
The company has also begun – and is near completion – of field trials in Brazil, and is also exploring facilities in Israel ….
Read full, original article: AquaBounty aiming to build new RAS sites overseas
